Approach to antiplatelet therapy in the context of digestive endoscopy
Introduction: The use of platelet antiaggregant agents is increasingly widespread in the world population. The decision regarding the endoscopic management of this treatment should be based on the type of medical indication that justifies the use of these medications. A review of the articles publis...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
Editorial Ciencias Médicas - ECIMED
2021-04-01
|
| Series: | Revista Cubana de Medicina Militar |
| Subjects: | |
| Online Access: | http://www.revmedmilitar.sld.cu/index.php/mil/article/view/702 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850043251798573056 |
|---|---|
| author | Eduardo Carlos Veitía Wilson Ludmila Martínez Leyva Tatiana Amable Días Misdrialis Martínez Romero Ignasio Morales Martínez Anilaydis Duvergel Zamora |
| author_facet | Eduardo Carlos Veitía Wilson Ludmila Martínez Leyva Tatiana Amable Días Misdrialis Martínez Romero Ignasio Morales Martínez Anilaydis Duvergel Zamora |
| author_sort | Eduardo Carlos Veitía Wilson |
| collection | DOAJ |
| description | Introduction: The use of platelet antiaggregant agents is increasingly widespread in the world population. The decision regarding the endoscopic management of this treatment should be based on the type of medical indication that justifies the use of these medications. A review of the articles published in the Pubmed, Scielo, Medline and Cochrane databases related to the subject was made.
Objective: To deepen the knowledge related to periendoscopic digestive antiplatelet therapy.
Development: Platelet antiaggregant are key in the treatment and prevention of vascular, cardiac or cerebral thrombotic events. Just as the indications of antithrombotic agents have been established, the thromboembolic risk has also been evaluated when treatment is suspended. The thromboembolic risk may be low or high, so the risk-benefit of discontinuing therapy in this context should be evaluated. All endoscopic procedures present a risk of bleeding considering the low risk of bleeding below 1 % and high risk above 1 %. The decision about anti-aggregation in the perioperative / periprocedural period depends not only on the balance between thrombotic and hemorrhagic risks, but also on the type and indication of antiplatelet therapy.
Conclusions: Platelet anti-aggregation in patients who will undergo interventional gastrointestinal procedures is observed more and more frequently. This makes knowledge about the risk assessment of thrombotic phenomena necessary when interrupting these drugs, together with the determination of the potential risk of bleeding according to the endoscopic procedure performed. |
| format | Article |
| id | doaj-art-8e67b3caec4c48c99c9c59a5946c121b |
| institution | DOAJ |
| issn | 1561-3046 1561-3046 |
| language | Spanish |
| publishDate | 2021-04-01 |
| publisher | Editorial Ciencias Médicas - ECIMED |
| record_format | Article |
| series | Revista Cubana de Medicina Militar |
| spelling | doaj-art-8e67b3caec4c48c99c9c59a5946c121b2025-08-20T02:55:17ZspaEditorial Ciencias Médicas - ECIMEDRevista Cubana de Medicina Militar1561-30461561-30462021-04-01502e0210702e0210702385Approach to antiplatelet therapy in the context of digestive endoscopyEduardo Carlos Veitía Wilson0Ludmila Martínez Leyva1Tatiana Amable Días2Misdrialis Martínez Romero3Ignasio Morales Martínez4Anilaydis Duvergel Zamora5Hospital Militar Central "Dr. Carlos J. Finlay"Hospital Militar Central "Dr. Carlos J. Finlay". La Habana, CubaHospital Militar Central "Dr. Carlos J. Finlay". La Habana, CubaHospital Militar Central "Dr. Carlos J. Finlay". La Habana, Cuba.Hospital "Celestino Hernández Robau". Santa Clara, Villa Clara.Facultad de Ciencias Médicas “Manuel Piti Fajardo”. Universidad de Ciencias Médicas de La Habana. La Habana, Cuba.Introduction: The use of platelet antiaggregant agents is increasingly widespread in the world population. The decision regarding the endoscopic management of this treatment should be based on the type of medical indication that justifies the use of these medications. A review of the articles published in the Pubmed, Scielo, Medline and Cochrane databases related to the subject was made. Objective: To deepen the knowledge related to periendoscopic digestive antiplatelet therapy. Development: Platelet antiaggregant are key in the treatment and prevention of vascular, cardiac or cerebral thrombotic events. Just as the indications of antithrombotic agents have been established, the thromboembolic risk has also been evaluated when treatment is suspended. The thromboembolic risk may be low or high, so the risk-benefit of discontinuing therapy in this context should be evaluated. All endoscopic procedures present a risk of bleeding considering the low risk of bleeding below 1 % and high risk above 1 %. The decision about anti-aggregation in the perioperative / periprocedural period depends not only on the balance between thrombotic and hemorrhagic risks, but also on the type and indication of antiplatelet therapy. Conclusions: Platelet anti-aggregation in patients who will undergo interventional gastrointestinal procedures is observed more and more frequently. This makes knowledge about the risk assessment of thrombotic phenomena necessary when interrupting these drugs, together with the determination of the potential risk of bleeding according to the endoscopic procedure performed.http://www.revmedmilitar.sld.cu/index.php/mil/article/view/702antiagregantes plaquetariosácido acetilsalicílicoclopidogrelendoscopia digestiva. |
| spellingShingle | Eduardo Carlos Veitía Wilson Ludmila Martínez Leyva Tatiana Amable Días Misdrialis Martínez Romero Ignasio Morales Martínez Anilaydis Duvergel Zamora Approach to antiplatelet therapy in the context of digestive endoscopy Revista Cubana de Medicina Militar antiagregantes plaquetarios ácido acetilsalicílico clopidogrel endoscopia digestiva. |
| title | Approach to antiplatelet therapy in the context of digestive endoscopy |
| title_full | Approach to antiplatelet therapy in the context of digestive endoscopy |
| title_fullStr | Approach to antiplatelet therapy in the context of digestive endoscopy |
| title_full_unstemmed | Approach to antiplatelet therapy in the context of digestive endoscopy |
| title_short | Approach to antiplatelet therapy in the context of digestive endoscopy |
| title_sort | approach to antiplatelet therapy in the context of digestive endoscopy |
| topic | antiagregantes plaquetarios ácido acetilsalicílico clopidogrel endoscopia digestiva. |
| url | http://www.revmedmilitar.sld.cu/index.php/mil/article/view/702 |
| work_keys_str_mv | AT eduardocarlosveitiawilson approachtoantiplatelettherapyinthecontextofdigestiveendoscopy AT ludmilamartinezleyva approachtoantiplatelettherapyinthecontextofdigestiveendoscopy AT tatianaamabledias approachtoantiplatelettherapyinthecontextofdigestiveendoscopy AT misdrialismartinezromero approachtoantiplatelettherapyinthecontextofdigestiveendoscopy AT ignasiomoralesmartinez approachtoantiplatelettherapyinthecontextofdigestiveendoscopy AT anilaydisduvergelzamora approachtoantiplatelettherapyinthecontextofdigestiveendoscopy |